1. Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature. (2nd June 2020) Authors: Caldarola, G.; Pirro, F.; Di Stefani, A.; Talamonti, M.; Galluzzo, M.; D'Adamio, S.; Magnano, M.; Bernardini, N.; Malagoli, P.; Bardazzi, F.; Potenza, C.; Bianchi, L.; Peris, K.; De Simone, C. Journal: Expert opinion on biological therapy Issue: Volume 20:Number 6(2020) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Consensus on the place in therapy of TNF‐α inhibitors in the treatment of patients with chronic plaque psoriasis. (20th May 2020) Authors: Gisondi, P.; Bellinato, F.; Conti, A.; Dapavo, P.; Piaserico, S.; De Simone, C.; Chiricozzi, A.; Dattola, A.; Malagoli, P.; Malara, G.; Campanati, A.; Burlando, M.; Esposito, M.; Gallo, L.; Girolomoni, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 9(2020) Page Start: e470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. COVID‐19 vaccination and patients with psoriasis under biologics: real‐life evidence on safety and effectiveness from Italian vaccinated healthcare workers. (1st August 2021) Authors: Damiani, G.; Allocco, F.; Malagoli, P. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 6(2021) Page Start: 1106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. COVID‐19 vaccination and patients with psoriasis under biologics: real‐life evidence on safety and effectiveness from Italian vaccinated healthcare workers. (4th April 2021) Authors: Damiani, G.; Allocco, F.; Malagoli, P. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 6(2021) Page Start: 1106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. COVID‐19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast. (1st October 2021) Authors: Pacifico, A.; d'Arino, A.; Pigatto, P. D. M.; Malagoli, P.; Young Dermatologists Italian Network, ; Damiani, G. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 7(2021) Page Start: 1344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. COVID‐19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast. (9th June 2021) Authors: Pacifico, A.; d'Arino, A.; Pigatto, P. D. M.; Malagoli, P.; Young Dermatologists Italian Network, ; Damiani, G. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 7(2021) Page Start: 1344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience. (1st June 2019) Authors: Conti, A.; Peccerillo, F.; Amerio, P.; Balato, A.; Bardazzi, F.; Bianchi, L.; Burlando, M.; Cannavò, S.P.; Chiricozzi, A.; Dapavo, P.; De Simone, C.; Fargnoli, M.C.; Gambardella, A.; Gisondi, P.; Malagoli, P.; Malara, G.; Mugheddu, C.; Offidani, A.M.; Piaserico, S.; Prignano, F. Journal: British journal of dermatology Issue: Volume 180:Number 6(2019) Page Start: 1547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience. (21st February 2019) Authors: Conti, A.; Peccerillo, F.; Amerio, P.; Balato, A.; Bardazzi, F.; Bianchi, L.; Burlando, M.; Cannavò, S.P.; Chiricozzi, A.; Dapavo, P.; De Simone, C.; Fargnoli, M.C.; Gambardella, A.; Gisondi, P.; Malagoli, P.; Malara, G.; Mugheddu, C.; Offidani, A.M.; Piaserico, S.; Prignano, F. Journal: British journal of dermatology Issue: Volume 180:Number 6(2019) Page Start: 1547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Infliximab biosimilar CT‐P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry. (1st December 2017) Authors: Gisondi, P.; Bianchi, L.; Conti, A.; Dapavo, P.; Malagoli, P.; Piaserico, S.; Savoia, F.; Prignano, F.; Girolomoni, G. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: e325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Infliximab biosimilar CT‐P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry. (22nd November 2017) Authors: Gisondi, P.; Bianchi, L.; Conti, A.; Dapavo, P.; Malagoli, P.; Piaserico, S.; Savoia, F.; Prignano, F.; Girolomoni, G. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: e325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗